Nomura Healthcare Fund Class C (DLHCX)

Fund Assets	745.76M
Expense Ratio	1.96%
Min. Investment	$1,000
Turnover	4.00%
Dividend (ttm)	2.69
Dividend Yield	10.72%
Dividend Growth	-17.70%
Payout Frequency	Annual
Ex-Dividend Date	Dec 2, 2025

Previous Close	25.59
YTD Return	11.81%
1-Year Return	32.30%
5-Year Return	68.99%
52-Week Low	21.08
52-Week High	25.75
Beta (5Y)	0.73
Holdings	108
Inception Date	Jan 28, 2010

About DLHCX

Macquarie Healthcare Fund Class C is an actively managed mutual fund that targets the healthcare and biotechnology sectors. Its primary purpose is to achieve maximum long-term capital growth through capital appreciation by investing at least 80% of its assets in equity securities of companies involved in the development, production, or distribution of healthcare products and services. The fund holds a diversified portfolio of over 110 securities, with the top ten positions making up nearly half of its total assets. Macquarie Healthcare Fund Class C is structured to provide focused exposure to healthcare, an industry recognized for its significant long-term growth potential and resilience to economic cycles. The fund’s assets exceed $600 million and it features an expense ratio of approximately 1.96%. It distributes dividends annually, with a notably high recent dividend yield, reflecting its active approach to both growth and income within the evolving healthcare landscape. The fund caters to investors seeking specialized access to healthcare equities within a single, professionally managed vehicle, reinforcing its role as a sector-specific portfolio solution in the broader financial market.

• Fund Family: Nomura
• Category: Health
• Performance Rating: Above Average
• Risk Rating: Below Average
• Stock Exchange: NASDAQ
• Ticker Symbol: DLHCX
• Share Class: Class C
• Index: Russell 3000 Healthcare TR

Performance

DLHCX had a total return of 32.30% in the past year, including dividends. Since the fund's inception, the average annual return has been 13.47%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
DLHIX	Institutional Class	0.96%
DLHAX	Class A	1.21%
DLRHX	Class R	1.46%

Top 10 Holdings

38.98% of assets

Name	Symbol	Weight
UCB SA	UCB	5.20%
AbbVie Inc.	ABBV	4.20%
Eli Lilly and Company	LLY	4.17%
Regeneron Pharmaceuticals, Inc.	REGN	3.91%
UnitedHealth Group Incorporated	UNH	3.89%
Pfizer Inc.	PFE	3.84%
Merck & Co., Inc.	MRK	3.69%
Gilead Sciences, Inc.	GILD	3.54%
AstraZeneca PLC	AZN	3.27%
Elevance Health, Inc.	ELV	3.25%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 2, 2025	$2.6853	Dec 2, 2025
Dec 3, 2024	$3.26278	Dec 4, 2024
Dec 4, 2023	$1.31011	Dec 5, 2023
Dec 2, 2022	$2.274	Dec 5, 2022
Dec 3, 2021	$1.476	Dec 6, 2021
Dec 4, 2020	$1.496	Dec 7, 2020

Data Sources: Tiingo, Twelve Data, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Twelve Data. Several fund data points are also provided by Finnhub.

Last checked:

Aug 27, 2026

Data Sources Report a data error